Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT04835129 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04835129
- Sponsor
- Medical College of Wisconsin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2027-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.